Takeda Pharmaceutical Company Limited 13D and 13G filings for Molecular Templates, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-14 06:13 am Sale | 2021-08-24 | 13D | Molecular Templates, Inc. MTEM | Takeda Pharmaceutical Company Limited | 154,311 4.100% | -40,556 (-20.81%) | Filing |